• Non ci sono risultati.

Ron A. Adelman, 1 Aaron J. Parnes, 2 Zofia Michalewska, 3 Barbara Parolini, 4 Claude Boscher, 5 Didier Ducournau, 6 and EVRS Macular Edema Study Group 6

N/A
N/A
Protected

Academic year: 2021

Condividi "Ron A. Adelman, 1 Aaron J. Parnes, 2 Zofia Michalewska, 3 Barbara Parolini, 4 Claude Boscher, 5 Didier Ducournau, 6 and EVRS Macular Edema Study Group 6"

Copied!
2
0
0

Testo completo

(1)

Corrigendum

Corrigendum to (Strategy for the Management of Diabetic Macular Edema: The European Vitreo-Retinal Society Macular Edema Study )

Ron A. Adelman, 1 Aaron J. Parnes, 2 Zofia Michalewska, 3 Barbara Parolini, 4 Claude Boscher, 5 Didier Ducournau, 6 and EVRS Macular Edema Study Group 6

1 Yale University School of Medicine, New Haven, CT, USA

2 Eyecare Medical Group, Portland, ME, USA

3 Ophthalmic Clinic “Jasne Blonia”, Lodz, Poland

4 Department of Ophthalmology, S. Anna Hospital, Brescia, Italy

5 American Hospital of Paris, Paris, France

6 EVRS, Nantes, France

Correspondence should be addressed to Ron A. Adelman; [email protected] Received 4 October 2015; Accepted 16 November 2015

Copyright © 2015 Ron A. Adelman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Through this corrigendum, the authors declare that the EVRS Macular Edema Study Group is a coauthor of the paper entitled “Strategy for the Management of Diabetic Macular Edema: The European Vitreo-Retinal Society Macular Edema Study” [1]. The names of “Ron Adelman” and “Aaron Parnes”

are corrected.

Acknowledgments

The authors of the EVRS Macular Edema Study Group are as follows: Walid Abdelghafar, Pierre Albinet, Saad Alkhalifa, Jean-Paul Amar, Oscar Aragon Harrison, Luis Arrevola, Francisco J. Ascaso, Samer Bashir, Frank Becquet, JeanPaul Berrod, Miguel Bilhoto, Silvia Bopp, Claude Boscher, Alexan- dra Brix, Perfecto E.O.R. Cagampang III, Slawomir Cisiecki, Jay F. Culotta, Marcel Dominguez, Giuseppe Donvito, Didier Ducournau, Ahmed El Khashab, Mohamed Nagy Elmo- hamady Saad, Maha Elshafei, Mario Facino, Natalia Ferreira, Ivan Fiser, Martin Flores-Aguilar, Eric Fourmaux, Evzen Fric, Wilko Friedrichs, Rino Frisina, Piotr Fryczkowski, Stratos Gotzaridis, H¨ulya G¨ungel, Fr´ed´eric Hamon, Fabian H¨ohn, Doan Hong Dung, Martin Hovorka, Angela Huiskamp, Mariano Iros, Slawomir Janiec, Young-Joon Jo, Muhammad

Shabbir Khan, Robert King, Dobromila Klimczak, Christine Kusserow, Guy L’Helgoual’ch, Pierre-Olivier Lafontaine, Jean- Franc¸ois Le Rouic, Jonghyun Lee, Oxana Levkina, Jean- Loup Leynaud, Aliki Liaska, Selina Lin, Luis Miguel Lopez Montero, Klaus Lucke, Angelina Meireles, Maurizio Mete, Zofia Michalewska, Janusz Michalewski, Jerzy Nawrocki, Agnieszka Nowosielska, Dominik Odrobina, Khor Sirwan Omer, ¨ Ozen Ayranci Osmanbasoglu, Ihab Saad Othman, Sengul Ozdek, Radu Pacurariu, Stefanie Pape, Barbara Parolini, Iwona Partyka, Enrico Peiretti, Isabel Pinxten, Prasan Rao, Armando Razzari, Daniel Roth, Armando San- doval, Andreas Sch¨uler, Stephen Sinclair, Peter Stalmans, Horia Stanca, Maria Stefaniotou, Yutthana Sukonthasap, Ivan Tanev, Susana Teixeira, Dimitrios Tsouris, and Zarifa Zeynalova.

References

[1] R. Adelman, A. Parnes, Z. Michalewska, B. Parolini, C. Boscher, and D. Ducournau, “Strategy for the management of diabetic macular edema: the European vitreo-retinal society macular edema study,” BioMed Research International, vol. 2015, Article ID 352487, 9 pages, 2015.

Hindawi Publishing Corporation

BioMed Research International

Volume 2015, Article ID 694902, 1 page

http://dx.doi.org/10.1155/2015/694902

(2)

Submit your manuscripts at http://www.hindawi.com

Stem Cells International

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

MEDIATORS

INFLAMMATION

of

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Behavioural Neurology

Endocrinology International Journal of

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Disease Markers

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

BioMed

Research International

Oncology Journal of

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Oxidative Medicine and Cellular Longevity

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

PPAR Research The Scientific World Journal

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Immunology Research

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Journal of

Obesity Journal of

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Computational and Mathematical Methods in Medicine

Ophthalmology Journal of

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Diabetes Research Journal of

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Research and Treatment

AIDS

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Gastroenterology Research and Practice

Hindawi Publishing Corporation

http://www.hindawi.com Volume 2014

Parkinson’s Disease

Evidence-Based Complementary and Alternative Medicine

Volume 2014 Hindawi Publishing Corporation

http://www.hindawi.com

Riferimenti

Documenti correlati

Advances in spectral-domain optical coherence tomography (SD-OCT) technology have enhanced the understand- ing of external limiting membrane (ELM) and ellipsoid zone (EZ) in

Based on selected international and Polish guidelines published in years 2012-2016 authors analyze what are the clinical recommendations in vision loss prevention

The model compared the effect on health, longevity, and costs of the following management strategies: no treatment; monotherapy with a VEGF inhibitor (ranibizumab, 0.3 mg);

3 Effect of MAGEs formation on the tertiary structure of MNEI: overlay of the near-UV CD spectra of MNEI (green) and gMNEI (pink) after 21 days of incubation.. (Color

The information root node variation (IRNV) method (based on decision trees) was used to get a rule set that provides useful information about the most probable causes of fatalities

All HER2-positive carcinomas except one grouped within the cluster enriched for HER2 amplicon–related genes together with 2 double-equivocal carcinomas classified as luminal B

These studies were considered eligible in that they combine all of the following chosen requirements: Double blinded randomized clinical trials, conducted with people,

The percentage of previously treated patients achieving ≥15-letter gain in BCVA from baseline at the year 3 or final study visit (primary efficacy endpoint) was 21.5 % in the